Compare PTCT & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | RUN |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.2B |
| IPO Year | 2013 | 2015 |
| Metric | PTCT | RUN |
|---|---|---|
| Price | $77.48 | $17.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 18 |
| Target Price | ★ $73.76 | $20.63 |
| AVG Volume (30 Days) | 2.3M | ★ 9.3M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 8.94 | N/A |
| Revenue | $1,779,150,000.00 | ★ $2,316,656,000.00 |
| Revenue This Year | $128.32 | $18.66 |
| Revenue Next Year | N/A | $6.33 |
| P/E Ratio | $8.64 | ★ N/A |
| Revenue Growth | ★ 97.54 | 13.79 |
| 52 Week Low | $35.95 | $5.38 |
| 52 Week High | $87.50 | $22.44 |
| Indicator | PTCT | RUN |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 43.75 |
| Support Level | $73.03 | $17.35 |
| Resistance Level | $79.03 | $20.31 |
| Average True Range (ATR) | 3.38 | 1.31 |
| MACD | -0.70 | -0.11 |
| Stochastic Oscillator | 29.37 | 16.70 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.